Format

Send to

Choose Destination
Oncotarget. 2017 Sep 8;8(43):75264-75271. doi: 10.18632/oncotarget.20769. eCollection 2017 Sep 26.

Whole-exome sequencing reveals genetic variants in ERC1 and KCNG4 associated with complete hydatidiform mole in Chinese Han women.

Author information

1
Key Laboratory of Women's Reproductive Health of Zhejiang Province, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
2
Department of Surgical Pathology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
3
Department of Gynecologic Oncology, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
4
Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
5
Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
6
Department of Obstetrics and Gynecology, West China Second Hospital of Sichuan University, Chengdu, Sichuan, China.
7
Department of Obstetrics and Gynecology, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China.
8
Department of Obstetrics and Gynecology, Shaoxing Women and Children Hospital, Shaoxing, Zhejiang, China.
9
Zhejiang University Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
10
Institute for Translational Medicine School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
11
Department of Clinical Laboratory, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
12
Sir Run Run Shaw Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Abstract

Complete hydatidiform mole (CHM) is a rare pregnancy-related disease with invasive potential. The genetics underlying the sporadic form of CHM have not been addressed previously, but maternal genetic variants may be involved in biparental CHM. We performed whole-exome sequencing of 51 patients with CHM and 47 healthy women to identify genetic variants associated with CHM. In addition, candidate variants were analyzed using single base extension and Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in 199 CHM patients and 400 healthy controls. We validated candidate variants using Sanger sequencing in 250 cases and 652 controls, including 205 new controls. Two single nucleotide polymorphisms, c.G48C(p.Q16H) inERC1 and c.G1114A(p.G372S) in KCNG4, were associated with an increased risk of CHM (p<0.05). These variants may contribute to the pathogenesis of CHM and could be used to screen pregnant women for this genetic abnormality.

KEYWORDS:

complete hydatidiform mole; genomics; pathogenesis; whole-exome sequencing

Conflict of interest statement

CONFLICTS OF INTEREST All authors have reviewed the manuscript and read the conflicts of interest notification. The authors declare that there are no conflicts of interest.

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center